Bone pain treatment market seen reaching $8.58 billion by 2030

Nov. 20, 2026
Bone pain treatment market seen reaching $8.58 billion by 2030
By AI, Created 14:30 UTC, Nov 20, 2026, AGP -

The Business Research Company says the global bone pain treatment market will grow from $6.05 billion in 2025 to $8.58 billion by 2030, driven by rising osteoporosis, fractures and broader use of non-opioid therapies. North America led the market in 2025, while Asia-Pacific is projected to be the fastest-growing region.

Why it matters: - Bone pain treatment demand is rising as aging populations, osteoporosis and cancer-related bone pain increase the need for effective pain management. - The market outlook points to a shift toward non-opioid, multimodal and rehabilitation-based care, which could reshape treatment choices and provider spending.

What happened: - The Business Research Company released its Bone Pain Treatment Global Market Report 2026, covering market size, trends and forecasts through 2035. - The report puts the global bone pain treatment market at $6.05 billion in 2025. - The market is projected to reach $6.5 billion in 2026, reflecting 7.5% annual growth. - The market is expected to climb to $8.58 billion by 2030, at a 7.2% compound annual growth rate. - The report says North America held the largest market share in 2025. - The report says Asia-Pacific is expected to be the fastest-growing region during the forecast period.

The details: - Bone pain treatment includes medications, physical therapies and, in some cases, surgery to ease pain tied to fractures, infections, cancer or chronic bone disease. - The report links recent market growth to fractures, bone metastasis from cancer, opioid-based pain management, orthopedic care in hospitals and an aging population. - Future growth is expected to be supported by tighter opioid regulations, broader use of non-pharmacological therapies, expanding oncology supportive care, rehabilitation services and greater focus on chronic pain management. - Market trends highlighted in the report include multimodal pain management, greater use of non-opioid treatments, cancer-related bone pain therapies, physical and rehabilitative care, and more personalized pain relief. - Osteoporosis is a major growth driver because it increases fracture risk as bone density falls with age. - The AO Foundation said in April 2023 that osteoporotic fractures occur every three seconds worldwide and affect about 8.9 million people each year. - The AO Foundation said U.S. costs tied to osteoporotic fractures are about $14 billion annually and are expected to more than double by 2025. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The company also said its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel dashboards, market hotspot infographics, and updated technology and trend analysis. - Download a free sample of the report. - View the full market report.

Between the lines: - The forecast suggests the bone pain treatment market is moving away from opioid-heavy care and toward broader pain-management approaches. - The emphasis on oncology supportive care and rehabilitation points to demand beyond short-term injury treatment. - Regional growth divergence suggests mature markets will continue to generate volume while faster expansion may come from emerging healthcare systems.

What's next: - The market will likely be shaped by how quickly providers adopt non-opioid treatments and integrated pain management models. - Growth may accelerate as rehabilitation services expand and chronic pain management becomes more central to care pathways. - The report’s forecast through 2030 gives investors, providers and suppliers a baseline for planning product development and market entry.

The bottom line: - Bone pain treatment is set for steady global expansion, with demand rising from aging, osteoporosis and cancer care while the market shifts toward safer and more diversified therapies.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Asia News Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Asia News Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.